Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference
Supernus Pharmaceuticals announced that CEO Jack A. Khattar will participate in a fireside chat at the Bank of America 2026 Health Care Conference. The company specializes in developing and commercializing treatments for central nervous system diseases, with a broad portfolio addressing ADHD, Parkinson's disease, postpartum depression, epilepsy, an…